Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody

Autor: Zeng, Shenxin a, b, c, ∗∗, Wu, Mingfei d, Jin, Yuyuan a, b, c, Ye, Yingqiao a, b, c, Xia, Heye a, b, c, Chen, Xinyi a, b, c, Che, Jinxin d, Wang, Zunyuan a, b, c, Wu, Ying a, Dong, Xiaowu d, ∗∗∗, Chen, Yinqiao a, ∗∗∗∗, Huang, Wenhai a, b, c, ∗
Zdroj: In European Journal of Medicinal Chemistry 5 March 2024 267
Databáze: ScienceDirect